MDMA Therapy Sydney
In 6 months (around June 2024) the FDA (US medicine regulator) will likely approve MDMA (ecstasy) as a licensed medicine in the US. This will present a pivotal moment for…
Spravato Clinics Australia
As Australia continues to explore innovative treatments for treatment-resistant depression (TRD) and other mental health conditions, esketamine has emerged as a promising therapy. Delivered via nasal spray under the brand…
Psilocybin Prescription UK
As of the last update of this article in October 2022, psilocybin remains a Class A drug in the UK, making it illegal to produce, supply, or possess. The following…
The common medicines which change our personality, a pharmacists confession.
When new drugs come to market they are granted a license by the government based on a very narrow view of the medicines effects. For instance, whilst drug firms have…
Are smartphone-based mental health apps any good for depression?
In the latter quarter of what seems to be the worst year ever, 2020, it seems the opportunities for slipping into clinical depression are exponentially increasing. The latest statistics show…
Psilocybin availability in the UK
When will psilocybin be legally available in the UK? It is no secret in the medical sector, that evidence for the efficacy of traditional antidepressants (SSRIs, SNRIs, NASSAs...) is underwhelming.…
Esketamine availability in Australia
Spravato is the brand name of esketamine, a glutamate receptor drug used for rapid depression treatment manufactured by Johnson & Johnson in the US. Esketamine is contained within the standard pharmaceutical…